Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.536 SEK
−64.89 M SEK
0.00 SEK
120.86 M
About KANCERA AB
Sector
CEO
Peter Selin
Headquarters
Solna
Website
Founded
2010
ISIN
SE0015658570
FIGI
BBG001Y25L94
Kancera AB engages in the research, development, and sale of drug candidates to pharmaceutical companies. It focuses on Fractalkine program which develops a candidate drugs for treatment of severe inflammatory diseases and cancer. The company was founded by Hakan Mellstedt on April 28, 2010 and is headquartered in Solna, Sweden.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of KAN is 1.160 SEK — it has decreased by −0.34% in the past 24 hours. Watch KANCERA AB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange KANCERA AB stocks are traded under the ticker KAN.
KAN stock has risen by 14.62% compared to the previous week, the month change is a 8.21% rise, over the last year KANCERA AB has showed a −75.26% decrease.
We've gathered analysts' opinions on KANCERA AB future price: according to them, KAN price has a max estimate of 1.50 SEK and a min estimate of 1.50 SEK. Watch KAN chart and read a more detailed KANCERA AB stock forecast: see what analysts think of KANCERA AB and suggest that you do with its stocks.
KAN stock is 15.48% volatile and has beta coefficient of 1.11. Track KANCERA AB stock price on the chart and check out the list of the most volatile stocks — is KANCERA AB there?
Today KANCERA AB has the market capitalization of 140.58 M, it has increased by 8.18% over the last week.
Yes, you can track KANCERA AB financials in yearly and quarterly reports right on TradingView.
KANCERA AB is going to release the next earnings report on Feb 21, 2025. Keep track of upcoming events with our Earnings Calendar.
KAN net income for the last quarter is −11.06 M SEK, while the quarter before that showed −10.90 M SEK of net income which accounts for −1.45% change. Track more KANCERA AB financial stats to get the full picture.
No, KAN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 25, 2024, the company has 3.00 employees. See our rating of the largest employees — is KANCERA AB on this list?
Like other stocks, KAN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KANCERA AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So KANCERA AB technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating KANCERA AB stock shows the sell signal. See more of KANCERA AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.